Cancer research
Favorable Safety Profile for m FBG in Neuroblastoma Patients
New research published in the Nuclear Medicine Communications journal has found a favorable safety profile for the PET radiopharmaceutical m FBG in patients with neuroblastoma. The study, conducted at Memorial Sloan-Kettering Cancer Center, involved 27 patients with neuroblastoma who underwent 18 F-m FBG PET imaging as part of a phase